This study retrospectively analyzed the changes of CEA, CYFRA 21–1, and SCC tumor markers, and explored the clinical efficacy of pemetrexed combined with platinum on NSCLC chemotherapy. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.